Key result
Prior statin therapy in patients with acute non-ST-elevation myocardial infarction was associated with a significant reduction in in-hospital death.
Why the study?
Does chronic statin pretreatment reduce in-hospital mortality and infarct size in patients with acute non-ST-elevation myocardial infarction?
Observational (n=6,358)
Yes
Does chronic statin pretreatment reduce in-hospital mortality and infarct size in patients with acute non-ST-elevation myocardial infarction?
Prior statin therapy in patients presenting with NSTEMI is associated with smaller infarct size and significantly reduced in-hospital mortality.
Answers are grounded in this paper and cite their sources.
Prior statin use associated with lower NSTEMI mortality; hypothesis-generating for pretreatment benefit and should not change practice without RCTs.
PURPOSE: We sought to investigate the impact of prior statin therapy on in-hospital outcome in patients presenting with acute non-ST-elevation myocardial infarction. METHODS AND RESULTS: We analyzed the data of consecutive patients with non-ST-elevation myocardial infarction who were prospectively enrolled in the German Acute Coronary Syndrome Registry between July 2000 and November 2002. Overall, 6358 patients were included, and we compared the patients who received statins before hospital admission (n = 1247, 19.6%) with those who did not (n = 5111, 80.4%). There was no age difference between the two groups; however, pretreated patients had a higher incidence of prior atherothrombotic events diabetes mellitus and renal insufficiency. The percentage of patients undergoing percutaneous coronary intervention and coronary artery bypass grafting was similar. Infarct size measured by peak creatine kinase level was lower in statin users (238 vs. 283 U/L, P < 0.0001). After adjustment for confounding variables, a significant reduction of in-hospital death could be observed in patients on statins (odds ratio 0.65, 95% confidence interval 0.46-0.90). CONCLUSIONS: In clinical practice, pretreatment with statins was associated with smaller myocardial infarction size (peak creatine kinase level) and a significant reduction of hospital mortality. However, the data were obtained from an observational study, and the results need further prospective confirmation.
No takes yet. Share an insight, caveat, or question.
Bauer et al. (2009) conducted an observational in Acute non-ST-elevation myocardial infarction (n=6,358). Prior statin therapy vs. No prior statin therapy was evaluated on In-hospital death (OR 0.65, 95% CI 0.46-0.90). Prior statin therapy in patients with acute non-ST-elevation myocardial infarction was associated with a significant reduction in in-hospital death.
Synapse has enriched 10 related papers. Consider them for comparative context: